PATENT CLAIM ANALYSIS

Application Number: 16007653
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "451000"]

Abstract:
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Claim (Index 43):
A solid oral controlled-release dosage form of hydrocodone, the dosage form comprising (i) hydrocodone or a pharmaceutically acceptable salt thereof, (ii) an anti-inflammatory agent or a pharmaceutically acceptable salt thereof and (iii) and a controlled release material comprising a material selected from the group consisting of gums, cellulose ethers, acrylic resins, waxes, shellac, oils, and mixtures thereof,\n the dosage form providing a W 50  of hydrocodone of between 4 and 22 hours and a plasma concentration of hydrocodone within a therapeutic range over a period of time of about 12 hours or longer after administration to a human patient, wherein the hydrocodone or pharmaceutically acceptable salt thereof and the anti-inflammatory agent or pharmaceutically acceptable salt thereof are the only active agents in the dosage form.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 94.0
- Lexical Diversity: 1.17857
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12914054', '15019695', '14612483', '15019609', '15019531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7898477451822192
- 35 USC 102 Novelty (BERT): 0.5686566144461905
- Combined Prediction Score: 0.7677286321086163
- Mean Citation Score: 458.683948
- Max Citation Score: 461.66776
- Similarity Product: 423.2141402507688

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test